Urpo Rinne suomalainen neurotieteilijä
Rinne, U.K.
Rinne, Urpo K.
Rinne, Urpo Kalervo, 1935-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Rinne, Urpo K., 1935-
Rinne, Urpo 1935-
VIAF ID: 54792728 (Personal)
Permalink: http://viaf.org/viaf/54792728
Preferred Forms
-
100 1 _
‡a
Rinne, U.K.
-
100 1 _ ‡a Rinne, U.K.
-
100 1 _ ‡a Rinne, Urpo K.
-
100 1 0
‡a
Rinne, Urpo K.
-
100 1 _
‡a
Rinne, Urpo K.
-
100 1 _ ‡a Rinne, Urpo K., ‡d 1935-
-
100 1 _
‡a
Rinne, Urpo Kalervo,
‡d
1935-....
-
100 1 _
‡a
Rinne, Urpo
‡d
1935-
-
100 0 _
‡a
Urpo Rinne
‡c
suomalainen neurotieteilijä
4xx's: Alternate Name Forms (11)
Works
| Title | Sources |
|---|---|
| Comparison of different long-acting corticotropin preparations in the two-day corticotropin test in man |
|
| The Effect of psychic and painful stimuli on the reproductive organs of the female rat |
|
| Excretion of noradrenaline, adrenaline and vanilmandelic acid in patients with cerebro-vascular disorders during prenylamine treatment |
|
| GABA receptor binding in the parkinsonian brain |
|
| [Guillain-Barré syndrome and its treatment] |
|
| How to proceed today in treatment : from basic research and early diagnosis to long-term treatment |
|
| Immune functions in Parkinson's disease lymphocyte subsets, concanavalin A-induced suppressor cell activity and in vitro immunoglobulin production |
|
| Level of blood pressure in patients with Parkinson's disease. A case-control study |
|
| Levodopa with benserazide or carbidopa in Parkinson disease |
|
| Long-term responses of Parkinson's disease to levodopa therapy |
|
| <Madopar> HBS : International Workshop on the "On-Off"-Phenomenon in Parkinsons̕ Disease : new possibilities for its management : Agno, November 14-16, 1985 |
|
| Maturational changes of CNS myelin with special reference to neutral proteinase activities |
|
| Myelin breakdown and basic protein |
|
| Nervous system inflammatory lesions and viral nucleic acids in rabbits with herpes simplex virus encephalitis-induced rotational behaviour |
|
| Neurochemical and morphological studies on demyelination in multiple sclerosis with special reference to etiological aspects |
|
| Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease |
|
| New strategies in the treatment of Parkinson's disease : symposium, Copenhagen, Denmark January 26-27, 1989 |
|
| The occurrence of dopamine and noradrenaline in the tubero-hypophysial system |
|
| Oxygen toxicity protecting enzymes in the human brain |
|
| Parkinson's disease : current progress, problems, and management : proceedings of the Northern European symposium on Parkinson's disease, Helsinki, November 6-8, 1979 |
|
| Peptidase activity of myelin during the myelination period in guinea-pig brain |
|
| PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease |
|
| PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756 |
|
| PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease |
|
| Platelet aggregation test with measles antigen in multiple sclerosis. |
|
| Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease |
|
| Protein and ganglioside composition of human central nervous system myelin |
|
| Proteinases in human cerebrospinal fluid |
|
| Proten composition of white matter myelin in subacute sclerosing panencephalitis. |
|
| [Rare extrapyramidal disorders: progressive supranuclear paralysis and striato-nigral degeneration] |
|
| Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain |
|
| The relation of essential tremor to Parkinson's disease |
|
| Selegiline |
|
| Selegiline in Parkinson's disease : an update : Satellite symposium to the second international congress on movement disorders, Munich, Germany, June 23, 1992 |
|
| Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease |
|
| Sleep movements and associated autonomic nervous activities in patients with Parkinson's disease |
|
| Slowing of information processing in Parkinson's disease |
|
| Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease |
|
| Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction |
|
| Striatal kinetics of [11C]- |
|
| Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques |
|
| Substance P immunoreactivity in the post-mortem parkinsonian brain |
|
| Superoxide dismutase-like activity in the Parkinson's disease brain |
|
| [Tardive dyskinesia] |
|
| Topographic Analysis of MS and Control Brains |
|
| Treatment of Parkinson's disease with amantadine and L-Dopa. |
|
| Ultrastructural studies of multiple sclerosis brain biopsies |
|
| Validity of clinical diagnosis in dementia: a prospective clinicopathological study |
|
| Virus antibodies in Parkinson's disease. Herpes simplex and measles virus antibodies in serum and CSF and their relation to HLA types |
|
| Virus antibodies in serum specimens from patients with multiple sclerosis, from siblings, and matched controls. A final report |
|
